BRIEF-Ventirx Pharma announces collaboration with Celgene Corp

Oct 3 (Reuters) - Celgene Corp :

* Ventirx pharmaceuticals announces exclusive, strategic collaboration for

development of novel tlr8 agonist vtx-2337 with Celgene Corporation

* Ventirx says as part of the strategic agreement, Celgene will retain the

exclusive option to acquire ventirx

* Ventirx-under deal, Celgene will provide a $35 million upfront payment to

fund further research and development of vtx-2337

((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))

((For more news, please click here ))